Associated Papers
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer.
Stensgaard S et al.
Translational Lung Cancer Research, 2023
37323168 (PubMed )
Supplement: tlcr-12-05-971-supplementary.pdf
Select a paper to view details